CSIMarket
 


Novabay Pharmaceuticals Inc   (NBY)
Other Ticker:  
 
 

Novabay Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Novabay Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 8.06, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Novabay Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 45 days, compared to 54 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 81 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 981, from overall ranking in the second quarter 2023 at 2097.

What is Receivable Turnover Ratio?
What is Novabay Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




NBY Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Receivable Change -57.06 % 138.89 % -20.22 % 18.29 % 153.02 %
Y / Y Revenue Change 11.29 % 71.14 % 62.1 % 83.42 % 19.55 %
Receivable Turnover Ratio (TTM) 8.06 6.78 7.23 5.91 5.3
NBY's Total Ranking # 981 # 2097 # 0 # 1595 # 2097
Average receivable collection period 45 54 50 62 69
Seq. Receivable Change -65.08 % 42.94 % -6.99 % -7.5 % 94.26 %
Seq. Revenue Change -34.09 % 0.58 % 26.84 % 32.35 % 1.35 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 82
Overall Market # 981

Receivable Turnover Ratio Statistics
High Average Low
1.59 0.66 -0.14
(Dec 31 2017)   (Sep. 30, 2014)






Financial Statements
Novabay Pharmaceuticals Inc 's Accounts Receivable $ 1 Millions Visit NBY's Balance sheet
Novabay Pharmaceuticals Inc 's Sales TTM $ 15 Millions Visit NBY's Income Statement
Where are NBY's Sales coming from? Visit NBY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NBY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for NBY's Competitors
Receivables Turnover Ratio for NBY's Suppliers
Accounts Receivables Turnover Ratio for NBY's Customers

You may also want to know
NBY's Growth Rates NBY's Roa NBY's Inventory Turnover Ratio NBY's Dividend Comparisons
NBY's Profitability Ratios NBY's Roi NBY's Asset Turnover Ratio NBY's Dividend Growth
NBY's Valuation Ratios NBY's Roe NBY's Financial Strength Ratios NBY's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Sangamo Therapeutics Inc   44.25 $ 201.420  Millions$ 4.552  Millions
Aclaris Therapeutics Inc   44.03 $ 21.432  Millions$ 0.487  Millions
Aridis Pharmaceuticals Inc   41.46 $ 22.359  Millions$ 0.539  Millions
Vivos Therapeutics Inc   41.42 $ 13.803  Millions$ 0.333  Millions
Mei Pharma Inc   40.65 $ 105.383  Millions$ 2.592  Millions
Vbi Vaccines Inc  40.26 $ 8.122  Millions$ 0.202  Millions
Lineage Cell Therapeutics Inc   40.10 $ 8.772  Millions$ 0.219  Millions
Spero Therapeutics Inc   38.72 $ 77.699  Millions$ 2.007  Millions
Lifemd Inc   38.63 $ 133.842  Millions$ 3.465  Millions
Neptune Wellness Solutions Inc   38.14 $ 43.724  Millions$ 1.146  Millions
Nature s Sunshine Products inc   37.58 $ 437.245  Millions$ 11.635  Millions
Electrocore Inc   37.19 $ 13.399  Millions$ 0.360  Millions
Sonida Senior Living Inc   35.91 $ 249.127  Millions$ 6.938  Millions
Fusion Pharmaceuticals Inc   34.91 $ 2.208  Millions$ 0.063  Millions
China Pharma Holdings Inc   34.57 $ 7.783  Millions$ 0.225  Millions
23andme Holding Co  31.43 $ 269.726  Millions$ 8.583  Millions
Inmed Pharmaceuticals Inc   31.18 $ 5.287  Millions$ 0.170  Millions
Nektar Therapeutics  28.21 $ 88.260  Millions$ 3.129  Millions
Stoke Therapeutics Inc   28.20 $ 9.248  Millions$ 0.328  Millions
Eargo Inc   27.36 $ 39.694  Millions$ 1.451  Millions
National Vision Holdings Inc   26.49 $ 2,088.996  Millions$ 78.870  Millions
Capricor Therapeutics inc   25.66 $ 14.050  Millions$ 0.548  Millions
Voyager Therapeutics Inc   25.34 $ 158.398  Millions$ 6.250  Millions
Neuroone Medical Technologies Corporation  25.25 $ 1.952  Millions$ 0.077  Millions
Cue Health Inc   25.20 $ 198.915  Millions$ 7.894  Millions
Adaptimmune Therapeutics Plc  23.54 $ 75.969  Millions$ 3.227  Millions
Molecular Templates inc   23.22 $ 18.064  Millions$ 0.778  Millions
Qilian International Holding Group Limited  23.16 $ 45.751  Millions$ 1.976  Millions
Cv Sciences Inc   23.08 $ 15.578  Millions$ 0.675  Millions
C4 Therapeutics Inc   23.06 $ 20.349  Millions$ 0.882  Millions

Date modified: 2023-11-12T07:34:13+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com